Sionna Therapeutics(SION),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SION Sionna Therapeutics

Market Closed 12-12 16:00:00 EST

42.77

+1.05

+2.52%

盘后44.00

+1.23+2.88%

17:56 EST

High43.20	Low41.32	Vol203.63K
Open41.63	D1 Closing41.72	Amplitude4.51%
Mkt Cap1.91B	Tradable Cap539.51M	Total Shares44.63M
T/O8.67M	T/O Rate1.61%	Tradable Shares12.61M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SION","market":"US","secType":"STK","nameCN":"Sionna Therapeutics","latestPrice":42.77,"timestamp":1765573200000,"preClose":41.72,"halted":0,"volume":203625,"hourTrading":{"tag":"盘后","latestPrice":44,"preClose":42.77,"latestTime":"17:56 EST","volume":2983,"amount":128834.06,"timestamp":1765580176694},"delay":0,"floatShares":12614300,"shares":44628788,"eps":-2.360424,"marketStatus":"Market Closed","change":1.05,"latestTime":"12-12 16:00:00 EST","open":41.63,"high":43.2,"low":41.32,"amount":8672642.059500001,"amplitude":0.045062,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.360424,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1738904400000,"exchange":"NASDAQ","adjPreClose":41.72,"postHourTrading":{"tag":"盘后","latestPrice":44,"preClose":42.77,"latestTime":"17:56 EST","volume":2983,"amount":128834.06,"timestamp":1765580176694},"volumeRatio":0.9489025587650926},"requestUrl":"/m/hq/s/SION/wiki","defaultTab":"wiki","newsList":[{"id":"2590532280","title":"Chief Legal Officer Jennifer Fitzpatrick Reports Disposal of Sionna Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590532280","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590532280?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:57","pubTimestamp":1765317449,"startTime":"0","endTime":"0","summary":"Jennifer Fitzpatrick, Chief Legal Officer of Sionna Therapeutics Inc., has reported a disposal of common shares of Sionna Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 09, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL7T1rjs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Chief Legal Officer Jennifer Fitzpatrick Reports Disposal of Sionna Therapeutics Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"gpt_icon":0},{"id":"2589183618","title":"Sionna Therapeutics Valuation Topping $2 Billion Is 'Too Optimistic', RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2589183618","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589183618?lang=en_us&edition=fundamental","pubTime":"2025-12-05 00:45","pubTimestamp":1764866728,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics'  valuation topping $2 billion is \"too optimistic\" as the company's early-stage cystic fibrosis program faces significant hurdles before proving itself in clinical trials, RBC Capital Markets said Thursday in a report.Interest in Sionna has been fueled by hopes of major upside and the stock's perceived connection to widely held Vertex Pharmaceuticals , and investor feedback to RBC's downgrade of Sionna on Monday to underperform from sector perform triggered \"significant feedback,\" according to the report.Sionna is developing small-molecule drugs designed to work alongside Vertex's widely used therapy Trikafta, aiming to improve outcomes for cystic fibrosis patients, the report said.RBC cited variability in Sionna's human bronchial epithelial assays, where Trikafta's performance appeared weaker than in Vertex's published studies, raising questions about the reliability of Sionna's comparisons and the likelihood of clinical benefit.Despite investor pushback, RBC maint","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1069344957.HKD","LU2362541513.USD","IE00B19Z3581.USD","LU1093756168.USD","LU0289739699.SGD","LU0320765992.SGD","LU2462157665.USD","LU0823416689.USD","LU0757428866.USD","IE0002141913.USD","LU1778281490.HKD","VRTX","BK4567","LU0234570918.USD","BK4139","LU0889565916.HKD","LU1430594728.SGD","LU1093756325.SGD","LU0256863811.USD","LU0109394709.USD","IE00B19Z9Z06.USD","BK4585","IE00B19Z3B42.SGD","LU2236285917.USD","LU2362540622.SGD","SION","LU2362541273.HKD","SG9999001176.SGD","SG9999001176.USD","SG9999013999.USD","SGXZ57979304.SGD","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU2417539215.USD","BK4533","LU1674673691.USD","IE00BFTCPJ56.SGD","VERX","BK4023","BK4532","LU1585245621.USD","IE0002270589.USD","LU2324357040.USD","LU0417517546.SGD","IE00B19Z9P08.USD","LU1815336091.USD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2456880835.USD"],"gpt_icon":0},{"id":"2588770472","title":"Sionna Therapeutics Shares Lower After RBC Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2588770472","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588770472?lang=en_us&edition=fundamental","pubTime":"2025-12-02 04:03","pubTimestamp":1764619389,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics  shares fell nearly 14% in recent Monday trading after RBC Capital Markets downgraded the stock to underperform from sector perform, while keeping its $24 price target.Trading volume stood at over 526,000, versus the daily average of about 300,000.Price: 37.53, Change: -6.04, Percent Change: -13.86","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SION"],"gpt_icon":0},{"id":"2588977511","title":"Sionna Therapeutics Cut to Underperform From Sector Perform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2588977511","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588977511?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:37","pubTimestamp":1764599820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SION/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 01, 2025 09:37 ET (14:37 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"gpt_icon":0},{"id":"2588721246","title":"RBC Downgrades Sionna Therapeutics to Underperform From Sector Perform, Keeps $24 Price Target, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2588721246","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588721246?lang=en_us&edition=fundamental","pubTime":"2025-12-01 19:29","pubTimestamp":1764588589,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics (SION) has an average rating of overweight and mean price target of $42.57, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SION"],"gpt_icon":0},{"id":"2588726128","title":"Sionna Therapeutics Inc : RBC Cuts to Underperform From Sector Perform","url":"https://stock-news.laohu8.com/highlight/detail?id=2588726128","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588726128?lang=en_us&edition=fundamental","pubTime":"2025-12-01 18:22","pubTimestamp":1764584562,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X70CR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION","BK4139"],"gpt_icon":0},{"id":"2586263296","title":"OrbiMed Advisors LLC Reports Disposal of Sionna Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586263296","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586263296?lang=en_us&edition=fundamental","pubTime":"2025-11-27 07:46","pubTimestamp":1764200777,"startTime":"0","endTime":"0","summary":"OrbiMed Advisors LLC has reported a disposal of common shares of Sionna Therapeutics Inc. , according to a recent SEC Form 4 filing. The report was filed jointly by OrbiMed Advisors LLC, GP VIII, and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL4FsZzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"gpt_icon":0},{"id":"2586296454","title":"Director Peter A. Thompson Reports Disposal of Sionna Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586296454","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586296454?lang=en_us&edition=fundamental","pubTime":"2025-11-27 07:42","pubTimestamp":1764200547,"startTime":"0","endTime":"0","summary":"Peter A. Thompson, Director, has reported a disposal of common shares of Sionna Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL3sk8Zq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Peter A. Thompson Reports Disposal of Sionna Therapeutics Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"gpt_icon":0},{"id":"2586318415","title":"RA Capital Management Reports Sale of Sionna Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586318415","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586318415?lang=en_us&edition=fundamental","pubTime":"2025-11-25 06:44","pubTimestamp":1764024245,"startTime":"0","endTime":"0","summary":"RA Capital Management, L.P. has reported a disposal of common shares of Sionna Therapeutics Inc., according to a recent SEC filing. Other reporting owners include RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., and RA Capital Nexus Fund III, L.P., among other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 24, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDLbLbGR0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"RA Capital Management Reports Sale of Sionna Therapeutics Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"gpt_icon":0},{"id":"2585805461","title":"Sionna Therapeutics to Present at Evercore and Citi Healthcare Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2585805461","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585805461?lang=en_us&edition=fundamental","pubTime":"2025-11-24 20:00","pubTimestamp":1763985621,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics Inc. will participate in the Citi 2025 Global Healthcare Conference on Thursday, December 4th, 2025, at 9:45 a.m. ET. Live webcasts of the presentation will be available on the company's investor relations website, with replays accessible following the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on November 24, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL3c5BgJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1366192091.USD","LU1201861249.SGD","IE00BSNM7G36.USD","LU0170899867.USD","LU0072461881.USD","LU0130517989.USD","LU0314104364.USD","LU0106831901.USD","LU1668664300.SGD","BK4207","IE00B3QW5Z07.USD","LU2417539215.USD","LU2125154935.USD","LU1244550221.USD","LU1244550577.SGD","LU0098860793.USD","LU0128525689.USD","BK4588","LU1791807156.HKD","LU1267930227.SGD","LU2236285917.USD","NDAQ","BK4139","LU0320765646.SGD","LU0648001328.SGD","LU1162221912.USD","SION","LU0477156953.USD","LU2095319765.USD","LU2125154778.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4585","LU0130102774.USD","LU2462157665.USD","IE00B64PRP62.GBP","BK4112","BK4566","LU2210149790.SGD","LU2210150020.SGD","LU0980610538.SGD","LU0052756011.USD","LU1244550494.USD","LU2456880835.USD","BK4559","LU0310800965.SGD","LU0162691827.USD","BK4504","BK4534","LU2360032135.SGD"],"gpt_icon":0},{"id":"2585461609","title":"Sionna Therapeutics to Participate in Upcoming December Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2585461609","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585461609?lang=en_us&edition=fundamental","pubTime":"2025-11-24 20:00","pubTimestamp":1763985600,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Nov.  24, 2025  (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm fo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/24/3193348/0/en/Sionna-Therapeutics-to-Participate-in-Upcoming-December-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4093","CF","BK4585","BK4588","SION"],"gpt_icon":0},{"id":"2584903505","title":"RA Capital Management Reports Disposal of Sionna Therapeutics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584903505","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584903505?lang=en_us&edition=fundamental","pubTime":"2025-11-20 09:44","pubTimestamp":1763603063,"startTime":"0","endTime":"0","summary":"RA Capital Management, L.P. has reported a disposal of common shares of Sionna Therapeutics Inc. , according to a recent SEC filing. Some of the reporting owners include RA Capital Healthcare Fund LP and RA Capital Nexus Fund, L.P., among other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 19, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL835bfk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"RA Capital Management Reports Disposal of Sionna Therapeutics Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"gpt_icon":0},{"id":"2584920227","title":"BUZZ-U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet","url":"https://stock-news.laohu8.com/highlight/detail?id=2584920227","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584920227?lang=en_us&edition=fundamental","pubTime":"2025-11-20 02:59","pubTimestamp":1763578756,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Viking, Valvoline, AlphabetEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL6N3WV0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNDK","TGT","GLBE","LZB","NUVL","OXY","RIOT","LOW","DLB","OKLO","CDE","FCX","KZIA","GEV","DOW","MSTR","ON","NVDA","PRAX","NNE","PLUG","DY","GLAD","PPL","RDW","ALZN","RAPP","STX","COIN","WDC","AGIO","CEVA","SION","CVX","COP","ACHR","GOOGL","SHBI","ZION","OLMA","NEM","OWL","ONCY","CSIQ","H","VVV","VTVT","SCCO","XOM","NNOX"],"gpt_icon":0},{"id":"2584946203","title":"BTIG Research Initiates Coverage on Sionna Therapeutics With Buy Rating, $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2584946203","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584946203?lang=en_us&edition=fundamental","pubTime":"2025-11-19 20:38","pubTimestamp":1763555909,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics, Inc. (SION) has an average rating of Buy and mean price target of $42.57, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SION"],"gpt_icon":0},{"id":"2584494889","title":"BUZZ-BTIG turns bullish on biotech sector, sees 2026 as 'banner year'","url":"https://stock-news.laohu8.com/highlight/detail?id=2584494889","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584494889?lang=en_us&edition=fundamental","pubTime":"2025-11-19 19:02","pubTimestamp":1763550134,"startTime":"0","endTime":"0","summary":"BUZZ-BTIG turns bullish on biotech sector, sees 2026 as 'banner year'** With eased interest rates and an uptick in M&A, BTIG says sentiment has been positive for small and mid-cap biotech stocks in 20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL6N3WV0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","SION","RAPP","VTVT","LU0320765992.SGD","BK4139","LU0109394709.USD","PRAX","BK4007"],"gpt_icon":0},{"id":"2584691712","title":"Sionna Therapeutics Initiated at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2584691712","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584691712?lang=en_us&edition=fundamental","pubTime":"2025-11-19 18:23","pubTimestamp":1763547780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SION/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 19, 2025 05:23 ET (10:23 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"gpt_icon":0},{"id":"2584463918","title":"U.S. RESEARCH ROUNDUP-Amgen, Crowdstrike, Micron Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2584463918","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584463918?lang=en_us&edition=fundamental","pubTime":"2025-11-19 15:17","pubTimestamp":1763536636,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Amgen, Crowdstrike, Micron TechnologyNov 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4N3WV0GT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR","SG9999015358.SGD","LU0127658192.USD","MBI","SG9999014542.SGD","BRBR","VTVT","IPAR","BK4549","KNTK","ZION","CRWD","LU1585245621.USD","ENR","89888","HD","BK1609","OLMA","LU2498475776.HKD","NUVB","RARE","LU0289739699.SGD","PRAX","LU0820561818.USD","AMGN","DASH","WCC","SION","FCX","PCVX","LU2756315664.SGD","LU0079474960.USD","RAPP","INCY","LGIH","UHS","COTY","LU2039709279.SGD","LU0353189763.USD","BK4548","LU0266013472.USD","LU2065170008.USD","MU","ZYME","TERN","DKS"],"gpt_icon":1},{"id":"2584469443","title":"Sionna Therapeutics: Promising Developments and Strategic Advancements Boost Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2584469443","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584469443?lang=en_us&edition=fundamental","pubTime":"2025-11-17 08:15","pubTimestamp":1763338511,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Debanjana Chatterjee has reiterated their bullish stance on SION stock, giving a Buy rating on November 5. Debanjana Chatterje...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-promising-developments-and-strategic-advancements-boost-price-target-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-promising-developments-and-strategic-advancements-boost-price-target-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"gpt_icon":0},{"id":"2583680933","title":"Bitdeer, Pacira BioSciences, Garrett Motion, and More Stocks See Action From Activist Investors -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2583680933","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583680933?lang=en_us&edition=fundamental","pubTime":"2025-11-15 07:00","pubTimestamp":1763161200,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Nov. 6 through Nov. 12, 2025. Source: VerityData. Pacira BioSciences  Doma Perpetual Capital Management raised its stake in the pain-management biopharmaceutical company to 2,936,794 shares. Doma did so through the purchase of 238,176 Pacira BioSciences shares from Sept. 10 through Oct. 7 at prices ranging from $23.77 to $26.50, on average. On Nov. 10, Doma issued an open letter to Pacira's board of directors, advocating for the company to hire bankers and conduct a formal sales process for the business. The letter cites \"management's unrelenting underperformance, out-of-control spending, and lack of prudent financial control.\". Following the latest sales, Cyrus Capital continues to own 7.3% of G","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNXC","BK4023","BK4124","PCRX","BK4600","BK4139","BK4106","IE00B66KJ199.SGD","ISBC","LU2065169927.USD","IE00B19Z4B17.USD","IE0031619046.USD","BK4226","BTDR","BK4007","GTX","IE00B7SZL793.SGD","LU2065170008.USD","SION","USDT.USD.HKCC","BK4211","LU2065171402.SGD","LU2065171311.SGD","USDT.USD.CC","BK4595"],"gpt_icon":1},{"id":"2581607664","title":"Sionna Therapeutics Advances CF Pipeline Amid Strong Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2581607664","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581607664?lang=en_us&edition=fundamental","pubTime":"2025-11-07 14:54","pubTimestamp":1762498496,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics, Inc. ( ($SION) ) has released its Q3 earnings. Here is a breakdown of the information Sionna Therapeutics, Inc. presented to i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sionna-therapeutics-advances-cf-pipeline-amid-strong-financials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sionna-therapeutics-advances-cf-pipeline-amid-strong-financials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CF","BK4093","BK4588","BK4585","BK4139","SION"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sionnatx.com","stockEarnings":[{"period":"1week","weight":0.0616},{"period":"1month","weight":0.1692},{"period":"3month","weight":0.8734},{"period":"6month","weight":1.6111},{"period":"1year","weight":1.3761},{"period":"ytd","weight":1.3761}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Sionna Therapeutics","nameEN":"Sionna Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sionna Therapeutics(SION),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Sionna Therapeutics(SION) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Sionna Therapeutics,SION,Sionna Therapeutics股票,Sionna Therapeutics股票老虎,Sionna Therapeutics股票老虎国际,Sionna Therapeutics行情,Sionna Therapeutics股票行情,Sionna Therapeutics股价,Sionna Therapeutics股市,Sionna Therapeutics股票价格,Sionna Therapeutics股票交易,Sionna Therapeutics股票购买,Sionna Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sionna Therapeutics(SION),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Sionna Therapeutics(SION) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction